Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies
about
Aptamer-Functionalized Nanoparticles as "Smart Bombs": The Unrealized Potential for Personalized Medicine and Targeted Cancer Treatment.Trabectedin for the treatment of breast cancer.The efficacy of trabectedin in treating ovarian cancer.Efficacy of trabectedin for the treatment of liposarcoma.Starvation tactics using natural compounds for advanced cancers: pharmacodynamics, clinical efficacy, and predictive biomarkers.
P2860
Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 March 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phase I study of the safety an ...... nts with advanced malignancies
@en
Phase I study of the safety an ...... ts with advanced malignancies.
@nl
type
label
Phase I study of the safety an ...... nts with advanced malignancies
@en
Phase I study of the safety an ...... ts with advanced malignancies.
@nl
prefLabel
Phase I study of the safety an ...... nts with advanced malignancies
@en
Phase I study of the safety an ...... ts with advanced malignancies.
@nl
P2093
P2860
P1476
Phase I study of the safety an ...... nts with advanced malignancies
@en
P2093
Eric Sherman
Louis M Weiner
Michael Bookman
Neal J Meropol
Roger B Cohen
Roland Knoblauch
Trilok Parekh
P2860
P2888
P304
P356
10.1007/S00280-015-2705-Z
P577
2015-03-20T00:00:00Z